Skip to main content
Have a personal or library account? Click to login
In vitro effects of β-cyclodextrin-complexed rufinamide on magnesium-free artificial cerebrospinal fluid-induced epileptiform neural activity Cover

In vitro effects of β-cyclodextrin-complexed rufinamide on magnesium-free artificial cerebrospinal fluid-induced epileptiform neural activity

Open Access
|Jul 2026

References

  1. Brandon M K. Common Substrates of Medication-Resistant Temporal Lobe Epilepsy: Hippocampal Sclerosis, Focal Cortical Dysplasia, and Combined Pathologies. Transl Neurosci Res Rev 2019;2. https://doi.org/10.36959/817/522.
  2. Thom M, Eriksson S, Martinian L, et al. Temporal Lobe Sclerosis Associated With Hippocampal Sclerosis in Temporal Lobe Epilepsy: Neuropathological Features. J Neuropathol Exp Neurol 2009;68:928–38. https://doi.org/10.1097/NEN.0b013e3181b05d67.
  3. Perucca E, Cloyd J, Critchley D, et al. Rufinamide: Clinical pharmacokinetics and concentration–response relationships in patients with epilepsy. Epilepsia 2008;49:1123–41. https://doi.org/10.1111/j.1528-1167.2008.01665.x.
  4. Kim JY, Lee CG, Yu HJ, et al. The Efficacy and Tolerability of Rufinamide in Intractable Pediatric Epilepsy. J Epilepsy Res 2012;2:33–7. https://doi.org/10.14581/jer.12009.
  5. Arroyo S. Rufinamide. Neurotherapeutics 2007;4:155–62. https://doi.org/10.1016/j.nurt.2006.11.006.
  6. Huang L, Xiao W, Wang Y, et al. Metabotropic glutamate receptors (mGluRs) in epileptogenesis: an update on abnormal mGluRs signaling and its therapeutic implications. Neural Regen Res 2023;19:360–8. https://doi.org/10.4103/1673-5374.379018.
  7. Mazzucchelli I, Rapetti M, Fattore C, et al. Development and validation of an HPLC-UV detection assay for the determination of rufinamide in human plasma and saliva. Analytical and Bioanalytical Chemistry 2011;401:1013–21. https://doi.org/10.1007/s00216-011-5126-9.
  8. Vecsernyés M, Fenyvesi F, Bácskay I, et al. Cyclodextrins, Blood–Brain Barrier, and Treatment of Neurological Diseases. Archives of Medical Research 2014;45:711–29. https://doi.org/10.1016/j.arcmed.2014.11.020.
  9. Szabó Z-I, Gál R, Gall Z, et al. Cyclodextrin complexation improves aqueous solubility of the antiepileptic drug, rufinamide: solution and solid state characterization of compound-cyclodextrin binary systems. Journal of Inclusion Phenomena and Macrocyclic Chemistry 2017;88:1–10. https://doi.org/10.1007/s10847-017-0710-z.
  10. Pytel M, Mercik K, Mozrzymas JW. Interaction between cyclodextrin and neuronal membrane results in modulation of GABAA receptor conformational transitions. British J Pharmacology 2006;148:413–22. https://doi.org/10.1038/sj.bjp.0706747.
  11. Anderson WW, Lewis DV, Swartzwelder HS. BRE 21901 Magnesium-free medium activates seizure-like events in the rat hippocampal slice n.d.
  12. Mody I, Lambert JD, Heinemann U. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. Journal of Neurophysiology 1987;57:869–88. https://doi.org/10.1152/jn.1987.57.3.869.
  13. Dulla CG, Janigro D, Jiruska P, et al. How do we use in vitro models to understand epileptiform and ictal activity? A report of the TASK1‐WG4 group of the ILAE/AES Joint Translational Task Force. Epilepsia Open 2018;3:460–73. https://doi.org/10.1002/epi4.12277.
  14. Zhang ZJ, Koifman J, Shin DS, et al. Transition to Seizure: Ictal Discharge Is Preceded by Exhausted Presynaptic GABA Release in the Hippocampal CA3 Region. J Neurosci 2012;32:2499–512. https://doi.org/10.1523/JNEUROSCI.4247-11.2012.
  15. Carlson HL, Laliberté C, Brooks BL, et al. Reliability and variability of diffusion tensor imaging (DTI) tractography in pediatric epilepsy. Epilepsy & Behavior 2014;37:116–22. https://doi.org/10.1016/j.yebeh.2014.06.020.
  16. Leys C, Ley C, Klein O, et al. Detecting outliers: Do not use standard deviation around the mean, use absolute deviation around the median. Journal of Experimental Social Psychology 2013;49:764–6. https://doi.org/10.1016/j.jesp.2013.03.013.
  17. Kiss RJ, Nagy ZA, Szentes Á, et al. In vitro modulation of seizure-like activity with β-Cyclodextrin-complexed Rufinamide. Acta Marisiensis - Seria Medica 2024;70. https://doi.org/10.2478/amma-2024-0020.
  18. Huusko N, Römer C, Ndode-Ekane XE, et al. Loss of hippo-campal interneurons and epileptogenesis: a comparison of two animal models of acquired epilepsy. Brain Struct Funct 2015;220:153–91. https://doi.org/10.1007/s00429-013-0644-1.
  19. Cameron MC, Zhan R, Nadler JV. Morphologic integration of hilar ectopic granule cells into dentate gyrus circuitry in the pilocarpine model of temporal lobe epilepsy. J of Comparative Neurology 2011;519:2175–92. https://doi.org/10.1002/cne.22623.
  20. Gáll Z, Vancea S, Szilágyi T, et al. Dose-dependent pharmacokinetics and brain penetration of rufinamide following intravenous and oral administration to rats. European Journal of Pharmaceutical Sciences 2015;68:106–13. https://doi.org/10.1016/j.ejps.2014.12.012.
DOI: https://doi.org/10.2478/orvtudert-2025-0006 | Journal eISSN: 2537-5059 | Journal ISSN: 1453-0953
Language: English
Page range: 74 - 85
Published on: Jul 2, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2026 Előd Bomher, Zsolt-András Nagy, Ádám Szentes, Rita-Judit Kiss, Károly Orbán-Kis, Tibor Szilágyi, published by Transylvanian Museum Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.